Literature DB >> 7972851

Cost-effectiveness analysis in heart disease, Part I: General principles.

J Kupersmith1, M Holmes-Rovner, A Hogan, D Rovner, J Gardiner.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7972851     DOI： 10.1016/s0033-0620(05)80041-6

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN： 0033-0620            Impact factor:   8.194


× No keyword cloud information.
  9 in total

Review 1.  A review of health care models for coronary heart disease interventions.

Authors:  K Cooper; S C Brailsford; R Davies; J Raftery
Journal:  Health Care Manag Sci       Date:  2006-11

Review 2.  Cost effectiveness of coronary heart disease prevention strategies in adults.

Authors:  A D Brown; A M Garber
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

3.  A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots.

Authors:  Elahe Khorasani; Majid Davari; Abbas Kebriaeezadeh; Farshad Fatemi; Ali Akbari Sari; Vida Varahrami
Journal:  Eur J Health Econ       Date:  2022-03-02

Review 4.  Cost efficiency of nuclear cardiology services in the modern health care environment.

Authors:  D Douglas Miller
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

Review 5.  Cost effectiveness of therapies for atrial fibrillation. A review.

Authors:  M P Teng; L E Catherwood; D P Melby
Journal:  Pharmacoeconomics       Date:  2000-10       Impact factor: 4.981

Review 6.  Cost-effectiveness analysis in diagnosis of cardiac disease: overview of its rationale and method.

Authors:  R E Patterson
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

7.  Costs and effectiveness of cardiac rehabilitation for dialysis patients following coronary bypass.

Authors:  Yijian Huang; Rebecca Zhang; Steven D Culler; Nancy G Kutner
Journal:  Kidney Int       Date:  2008-07-23       Impact factor: 10.612

Review 8.  Pharmacoeconomics of lipid-lowering agents for primary and secondary prevention of coronary artery disease.

Authors:  J W Hay; W M Yu; T Ashraf
Journal:  Pharmacoeconomics       Date:  1999-01       Impact factor: 4.558

9.  Economic analysis including long-term risks and costs of alternative diagnostic strategies to evaluate patients with chest pain.

Authors:  Gigliola Bedetti; Emilio Maria Pasanisi; Carmine Pizzi; Giuseppe Turchetti; Cosimo Loré
Journal:  Cardiovasc Ultrasound       Date:  2008-05-29       Impact factor: 2.062
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.